Emerging Medicine Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Mathematical Sandbox: How Quantitative Systems Pharmacology Steers Safer, Faster Drug Development
Fear and anxiety swirled when Dr. Cynthia J. Musante’s husband contracted COVID-19. He faced agreater risk of coming down with a severe case since he was already unwell.But all their worries vanished in just 24 hours.Dr. Musante recalls that her husband soon started to feel better after being prescribed an investigational oral treatment for those with COVID-19. “It felt like a miracle,” he said. “I had felt so horrible.”As relief settled in, Dr. Musante felt something else: pride.After all, from...
Listen Now—Science Will Win Season 2 Takes on Breast Cancer
Science Will Win, one of Pfizer’s premiere podcasts, is back! This season we’ll explore the advancements and the challenges of cancer treatments, particularly in the breast cancer space. In this special two-part series, we’re looking at how the increasingly innovative medications used to treat cancer come to be.Part one: Breast Cancer: The Science, The Challenges, The Solutions Get a better sense of what breast cancer is and dive into some of the early-stage research underway to find new...
Finding Breakthroughs in Sickle Cell Disease: Patients and Advocates Lead the Way
In most types of clinical research, a large number of patients participate in studies that explore an experimental treatment or approach. This decades-old process is how some of the most impactful, and even lifesaving therapies have come to be, from cancer drugs to COVID-19 vaccines.1 But what happens when scientists need to study a rare disease, one that doesn’t affect a high percentage of people? And what if those who are affected don’t participate because of social disparities...
Pfizer’s Institute of Translational Equitable Medicine Addresses Equity in Health Research
When it comes to healthcare, the terms “equitable” and "access" often go hand-in-hand. In order to prevent, treat, and identify diseases that disproportionately impact underserved and minority populations, Pfizer believes that research must be directed to the root causes of healthcare disparities. The recently-launched Institute of Translational Equitable Medicine (ITEM) is intended to do just that: work toward a more equitable future of health care. For Aida Habtezion, M.D., who is Pfizer’s...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.